Literature DB >> 23070641

Imaging: Use of MRI as an outcome measure in clinical trials in RA.

Annette H M van der Helm-van Mil.   

Abstract

Mesh：

Year:  2012        PMID： 23070641     DOI： 10.1038/nrrheum.2012.182

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

1.  Rapid radiological progression in the first year of early rheumatoid arthritis is predictive of disability and joint damage progression during 8 years of follow-up.

Authors:  M van den Broek; L Dirven; J K de Vries-Bouwstra; A J Dehpoor; Y P M Goekoop-Ruiterman; A H Gerards; P J S M Kerstens; T W J Huizinga; Wf Lems; C F Allaart
Journal:  Ann Rheum Dis       Date:  2012-04-24       Impact factor: 19.103

2.  Significant improvement in synovitis, osteitis, and bone erosion following golimumab and methotrexate combination therapy as compared with methotrexate alone: a magnetic resonance imaging study of 318 methotrexate-naive rheumatoid arthritis patients.

Authors:  Mikkel Østergaard; Paul Emery; Philip G Conaghan; Roy Fleischmann; Elizabeth C Hsia; Weichun Xu; Mahboob U Rahman
Journal:  Arthritis Rheum       Date:  2011-12

3.  No overall progression and occasional repair of erosions despite persistent inflammation in adalimumab-treated rheumatoid arthritis patients: results from a longitudinal comparative MRI, ultrasonography, CT and radiography study.

Authors:  Uffe Møller Døhn; Bo Ejbjerg; Annelies Boonen; Merete Lund Hetland; Michael Sejer Hansen; Lene Surland Knudsen; Annette Hansen; Ole Rintek Madsen; Maria Hasselquist; Jakob M Møller; Mikkel Ostergaard
Journal:  Ann Rheum Dis       Date:  2010-10-26       Impact factor: 19.103

4.  MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA).

Authors:  M L Hetland; B Ejbjerg; K Hørslev-Petersen; S Jacobsen; A Vestergaard; A G Jurik; K Stengaard-Pedersen; P Junker; T Lottenburger; I Hansen; L S Andersen; U Tarp; H Skjødt; J K Pedersen; O Majgaard; A J Svendsen; T Ellingsen; H Lindegaard; A F Christensen; J Vallø; T Torfing; E Narvestad; H S Thomsen; M Ostergaard
Journal:  Ann Rheum Dis       Date:  2008-04-03       Impact factor: 19.103

Review 5.  Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change.

Authors:  K Bruynesteyn; M Boers; P Kostense; S van der Linden; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2004-07-29       Impact factor: 19.103

6.  Monitoring anti-TNFalpha treatment in rheumatoid arthritis: responsiveness of magnetic resonance imaging and ultrasonography of the dominant wrist joint compared with conventional measures of disease activity and structural damage.

Authors:  E A Haavardsholm; M Østergaard; H B Hammer; P Bøyesen; A Boonen; D van der Heijde; T K Kvien
Journal:  Ann Rheum Dis       Date:  2008-11-19       Impact factor: 19.103

7.  Synovitis and osteitis are very frequent in rheumatoid arthritis clinical remission: results from an MRI study of 294 patients in clinical remission or low disease activity state.

Authors:  Frédérique Gandjbakhch; Philip G Conaghan; Bo Ejbjerg; Espen A Haavardsholm; Violaine Foltz; Andrew K Brown; Uffe Møller Døhn; Marissa Lassere; Jane Freeston; Pernille Bøyesen; Paul Bird; Bruno Fautrel; Merete Lund Hetland; Paul Emery; Pierre Bourgeois; Kim Hørslev-Petersen; Tore K Kvien; Fiona McQueen; Mikkel Ostergaard
Journal:  J Rheumatol       Date:  2011-09       Impact factor: 4.666

8.  Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial.

Authors:  Philip G Conaghan; Paul Emery; Mikkel Østergaard; Edward C Keystone; Mark C Genovese; Elizabeth C Hsia; Weichun Xu; Mahboob U Rahman
Journal:  Ann Rheum Dis       Date:  2011-07-21       Impact factor: 19.103

9.  Exploratory analyses of the association of MRI with clinical, laboratory and radiographic findings in patients with rheumatoid arthritis.

Authors:  Paul Emery; Désirée van der Heijde; Mikkel Ostergaard; Philip G Conaghan; Mark C Genovese; Edward C Keystone; Roy Fleischmann; Elizabeth C Hsia; Weichun Xu; Stephen Xu; Mahboob U Rahman
Journal:  Ann Rheum Dis       Date:  2011-09-16       Impact factor: 19.103

10.  Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trial.

Authors:  Philip G Conaghan; Patrick Durez; Rieke E Alten; Gerd-Rüdiger Burmester; Paul P Tak; Lars Klareskog; Anca Irinel Catrina; Julie DiCarlo; Corine Gaillez; Manuela Le Bars; Xianhuang Zhou; Charles Peterfy
Journal:  Ann Rheum Dis       Date:  2012-08-21       Impact factor: 19.103
  10 in total
  2 in total

Review 1.  Insights into rheumatoid arthritis from use of MRI.

Authors:  Fiona M McQueen; Estee Chan
Journal:  Curr Rheumatol Rep       Date:  2014-01       Impact factor: 4.592

Review 2.  Juvenile idiopathic arthritis - the role of imaging from a rheumatologist's perspective.

Authors:  Clara Malattia; Nikolay Tzaribachev; J Merlijn van den Berg; Silvia Magni-Manzoni
Journal:  Pediatr Radiol       Date:  2018-05-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.